Published May 29, 2024
| Version v1
Journal article
Open
Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice
Creators
- 1. Cincinnati Children's Hospital Medical Center
- 2. University of Chicago
Description
Nuclear envelope (NE) ruptures are emerging observations in Lamin-related dilated cardiomyopathy, an adult-onset disease caused by loss-of-function mutations in Lamin A/C, a nuclear lamina component. Here, we test a prevailing hypothesis that NE ruptures trigger the pathological cGAS-STING cytosolic DNA-sensing pathway using a mouse model of Lamin cardiomyopathy. The reduction of Lamin A/C in cardio-myocyte of adult mice causes pervasive NE ruptures in cardiomyocytes, preceding inflammatory transcription, fibrosis, and fatal dilated cardiomyopathy. NE ruptures are followed by DNA damage accumulation without causing immediate cardiomyocyte death. However, cGAS-STING-dependent inflammatory signaling remains inactive. Deleting cGas or Sting does not rescue cardiomyopathy in the mouse model. The lack of cGAS-STING activation is likely due to the near absence of cGAS expression in adult cardiomyocytes at baseline. Instead, extracellular matrix (ECM) signaling is activated and predicted to initiate pro-inflammatory communication from Lamin-reduced cardiomyocytes to fibroblasts. Our work nominates ECM signaling, not cGAS-STING, as a potential inflammatory contributor in Lamin cardiomyopathy.
Data availability
High-throughput sequencing data have been deposited at Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and are publicly available as of the date of publication. Accession numbers are listed in Key resources table.
This paper does not report original codes.
Any additional information required to reanalyze the data reported in this paper is available from Lead Contact upon request.
Files
Pervasive-nuclear-envelope-ruptures-precede-ECM-signaling-and-disease-onset.pdf
Files
(40.4 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:afff2323c44ab66d21a9e09053b7db3a |
7.4 MB | Preview Download |
|
md5:8384d8e5079246670b827868ad7079f3
|
33.0 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1016/j.celrep.2024.114284
- Other
- oai:uchicago.tind.io:12294
Funding
- National Institutes of Health
- R21/R33 AG054770
- Cincinnati Children's Hospital Medical Center
- Research Innovation and Pilot grant
- National Institutes of Health
- R01 HL163523
- National Institutes of Health
- R01 HL124836
- National Institutes of Health
- R01 HL126509